Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

Treatment decisions for older adults with advanced chronic kidney disease.

Rosansky SJ, Schell J, Shega J, Scherer J, Jacobs L, Couchoud C, Crews D, McNabney M.

BMC Nephrol. 2017 Jun 19;18(1):200. doi: 10.1186/s12882-017-0617-3. Review.

2.

Managing Chronic Kidney Disease in Older People.

Rosansky SJ.

JAMA. 2016 Jan 19;315(3):306-7. doi: 10.1001/jama.2015.15993. No abstract available.

PMID:
26784784
3.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*.

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.

4.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.

5.

Starting dialysis at eGFR >5 ml/min per1.73 m(2): are we barking up the wrong tree?

Rosansky SJ, Durkin MW.

Kidney Int. 2014 Oct;86(4):673-5. doi: 10.1038/ki.2014.164.

PMID:
25265950
6.

Is a decline in estimated GFR an appropriate surrogate end point for renoprotection drug trials?

Rosansky SJ, Glassock RJ.

Kidney Int. 2014 Apr;85(4):723-7. doi: 10.1038/ki.2013.506. No abstract available.

PMID:
24682115
7.

Early dialysis initiation, a look from the rearview mirror to what's ahead.

Rosansky SJ.

Clin J Am Soc Nephrol. 2014 Feb;9(2):222-4. doi: 10.2215/CJN.12231213. Epub 2014 Jan 16. No abstract available.

8.

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, Leehey DJ, McCullough PA, O'Connor T, Palevsky PM, Reilly RF, Seliger SL, Warren SR, Watnick S, Peduzzi P, Guarino P; VA NEPHRON-D Investigators.

N Engl J Med. 2013 Nov 14;369(20):1892-903. doi: 10.1056/NEJMoa1303154. Epub 2013 Nov 9. Erratum in: N Engl J Med. 2014;158:A7255.

9.

Dialysis initiation: what's the rush?

Rosansky SJ, Cancarini G, Clark WF, Eggers P, Germaine M, Glassock R, Goldfarb DS, Harris D, Hwang SJ, Imperial EB, Johansen KL, Kalantar-Zadeh K, Moist LM, Rayner B, Steiner R, Zuo L.

Semin Dial. 2013 Nov-Dec;26(6):650-7. doi: 10.1111/sdi.12134. Epub 2013 Sep 19. Review.

PMID:
24066675
10.

Has the yearly increase in the renal replacement therapy population ended?

Rosansky SJ, Clark WF.

J Am Soc Nephrol. 2013 Sep;24(9):1367-70. doi: 10.1681/ASN.2013050458. Epub 2013 Jul 18.

11.

The authors reply.

Rosansky SJ, McIntyre CW.

Kidney Int. 2013 May;83(5):968. doi: 10.1038/ki.2013.19. No abstract available.

12.

Is hypertension overtreatment a silent epidemic?

Rosansky S.

Arch Intern Med. 2012 Dec 10;172(22):1769; author reply 1770. doi: 10.1001/2013.jamainternmed.96. No abstract available.

PMID:
23229941
13.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS.

N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.

14.

Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia.

Abraham WT, Hensen J, Gross PA, Bichet DG, Josiassen RC, Chafekar DS, Orlandi C; LIBRA Study Group.

Kidney Int. 2012 Dec;82(11):1223-30. doi: 10.1038/ki.2012.275. Epub 2012 Aug 29.

15.

Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease.

Rosansky SJ.

Am J Nephrol. 2012;36(1):1-10. doi: 10.1159/000339327. Epub 2012 Jun 13. Review.

16.

The sad truth about early initiation of dialysis in elderly patients.

Rosansky SJ.

JAMA. 2012 May 9;307(18):1919-20. doi: 10.1001/jama.2012.3522. No abstract available.

PMID:
22570459
17.

Starting dialysis is dangerous: how do we balance the risk?

McIntyre CW, Rosansky SJ.

Kidney Int. 2012 Aug;82(4):382-7. Review. Erratum in: Kidney Int. 2013 Feb;83(2):354.

18.

The European Renal Best Practice Advisory Board's dialysis initiation guidelines: one size won't fit all.

Rosansky SJ.

Kidney Int. 2011 Nov;80(10):1005-7. doi: 10.1038/ki.2011.295. No abstract available.

19.
20.

Early start of dialysis: a critical review.

Rosansky S, Glassock RJ, Clark WF.

Clin J Am Soc Nephrol. 2011 May;6(5):1222-8. doi: 10.2215/CJN.09301010. Review.

Supplemental Content

Loading ...
Support Center